Skip to main content

Why Indirect Costs on Research Grants are Essential for Universities

In recent days, there has been discussion about the "overheads" or "indirect" costs that universities add on to the cost of research projects. This has been driven by a decision by the US government to reduce the indirect costs of research on grants awarded by the US National Institutes of Health (NIH) from the current 60% to 15%. Comments from people such as Elon Musk has suggested these costs are wasteful and can therefore be easily cut from research grants. In this blog, I make the case for retaining a fair amount of indirect costs on research grants.

Without the indirect costs that universities receive on government research grants, universities would struggle to provide the essential support and infrastructure required for high-quality research to take place. While direct research costs (such as staff salaries, laboratory equipment, travel and consumables) are essential, they are only part of the funding needed. Research relies heavily on a wide array of indirect resources that ensure long-term sustainability, efficiency, and the proper functioning of universities.

Indirect costs include funding for essential services, such as maintaining research facilities and buildings, providing IT infrastructure and support, managing financial systems, and ensuring compliance through administrative and monitoring processes. Without adequate funding to cover these areas, research projects would be more difficult to complete successfully.

To address this challenge and ensure that universities receive adequate funding beyond direct project expenses, the UK government introduced the Full Economic Costs model. The Full Economic Costs model is designed to fairly and transparently allocate funding that covers the full range of costs associated with research activities.

Under this system, universities are able to recover a more realistic portion of the actual costs incurred in hosting and conducting research, helping to bridge the gap between the direct funding provided by grants and the true expenses they face. This model recognises that indirect costs, although not always visible at the project level, are vital to the successful completion and long-term sustainability of research projects.

The issue of indirect cost recovery is not unique to the UK. In the United States, for example, universities receive indirect cost reimbursements through a negotiated rate with federal agencies, but this system now also faces scrutiny over transparency and fairness. Comparisons like these highlight the importance of continually refining models such as the Full Economic Costs model to ensure they remain fair value for governments, taxpayers and universities.

The successful delivery of research projects relies on more than just securing grants for individual projects. It requires a support system that includes well-maintained buildings and other facilities, appropriate technology, efficient administrative processes, and skilled personnel; all of which are sustained by indirect funding.

Comments

Popular posts from this blog

Protecting Against the "Quad-demic": Influenza, Covid-19, Norovirus and RSV

As the NHS braces for a challenging winter season, it is grappling with a "quad-demic" of health emergencies caused by influenza, Covid-19, norovirus, and respiratory syncytial virus (RSV). This confluence of viral threats poses a significant risk to public health in the UK as well as putting strain on healthcare resources, emphasising the importance of preventive measures to safeguard public health. Public health measures such a vaccination and good personal hygiene are pivotal in reducing the impact of these illnesses, particularly for vulnerable groups. The Four Viruses: What Are They? Influenza: A highly contagious respiratory infection that causes significant illness each winter. It can lead to severe complications, particularly in the elderly, young children, pregnant women, and those with chronic health conditions. Covid-19: Though its most acute phase has passed, Covid-19 remains a concern, especially as new variants of SA...

MPH Student Presentations on the NHS Care.Data Programme

As part of a session on primary care data in the Health Informatics module on the Imperial Master of Public Health Programme, I asked students to work in two groups to present arguments for and against the NHS Care.Data programme. Care.Data is an NHS programme that will extract data from the medical records held by general practitioners (GPs) in England. The Care.Data programme takes advantage of the very high level of use of electronic medical records by GPs in England. After extraction, data will be uploaded to the NHS Health and Social Care Information Centre (HSCIC). The data will then be used for functions such as health care planning, monitoring disease patterns and research. The programme has been controversial with proponents arguing that the programme will bring many benefits for the NHS and the population of England; and opponents arguing it is a major breach of privacy. You can view the two presentations to help inform you further about these arguments: Arguments fo...

How can we work successfully across the health and care system to make a success of Pharmacy First?

Pharmacies in England to begin treating patients for seven common conditions. How can we work successfully across the health and care system to make a success of Pharmacy First? 1. The Pharmacy First scheme aims to provide convenient access to healthcare through community pharmacies. Patients with minor ailments or common conditions can seek advice and treatment directly from their local pharmacy instead of visiting a general practice, urgent care centre or emergency department. The conditions covered by the scheme may vary depending on local funding arrangements and participation of pharmacies.  2, A potential problem with Pharmacy First is pharmacists misdiagnosing a patient's condition. It may also lead to delays in patients seeing doctors when medical assessment is needed. To mitigate these risks, appropriate safeguards and referral pathways should be established, ensuring timely medical assessment when necessary. The scheme will also increase the workload of pharmacies, thereb...